Clinical Trials

GastrointestinalGenitourinaryThoracic

95 enrolled

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT02091141 2024-07-23

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

GastrointestinalGenitourinary

673 enrolled 22 charts

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Neoplasms

NCT04165031 2021-11-24

A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation

Phase 1/2 Terminated

5 enrolled 9 charts

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT01782690 2018-07-23

An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Completed

338 enrolled 18 charts

Pancreatic Neoplasms

NCT00033241 2018-01-10

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Pancreatic Neoplasms

NCT00040183 2018-01-10

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Phase 3 Completed

569 enrolled

Pancreatic Neoplasms

NCT02694536 2017-03-24

A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Phase 3 Completed

80 enrolled 10 charts

Pancreatic Neoplasms

NCT00642733 2016-08-24

A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase 4 Terminated

6 enrolled

Pancreatic Neoplasms

NCT00674973 2016-06-17

A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer

207 enrolled 12 charts

Pancreatic Neoplasms

NCT00461708 2015-10-15

A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival

153 enrolled 16 charts

Pancreatic Neoplasms

NCT00925769 2015-08-07

ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

32 enrolled 13 charts

Pancreatic Neoplasms

NCT00652366 2015-02-11

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

467 enrolled 21 charts

Pancreatic Neoplasms

NCT01135498 2015-02-06

A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.

90 enrolled 11 charts

Colorectal Neoplasms

NCT00605722 2014-07-14

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

51 enrolled 12 charts

Liver Neoplasms

NCT00709826 2012-11-07

APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer

109 enrolled 9 charts

Pancreatic Neoplasms

NCT00603356 2011-09-27

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

GastrointestinalGynecologicOther solid neoplasmSarcomaThoracic

60 enrolled

Mesothelioma, Neoplasms, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms

NCT00791544 2010-08-04

Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma

Phase 1/2 Terminated

13 enrolled

Carcinoma, Hepatocellular

NCT00536770 2007-11-06

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Phase 2 Suspended

132 enrolled

Pancreatic Neoplasms

NCT00047762 2005-06-24

Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer